Skip to main content
Equibles

MORGAN STANLEY

Position in MESO — Mesoblast Ltd

CIK 895421 NEW YORK, NY
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,722,764
+$1,810,818 QoQ
Shares Held
718,608
+39.7% QoQ
Ownership
0.553%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 72 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. MESO ranks #140 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in MESO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,722,764 718,608
2026-03-31 $7,911,946 514,431
2025-12-31 $10,769,011 596,952
2025-09-30 $7,504,052 465,801
2025-06-30 $5,492,816 504,391
2025-03-31 $6,796,069 544,557
2024-12-31 $7,967,460 402,397
2024-09-30 $1,418,270 173,595
2024-06-30 $569,431 83,617
2024-03-31 $345,198 68,902
2023-12-31 $341,487 310,444
2023-09-30 $110,500 89,838
2023-06-30 $839,406 214,682
2023-03-31 $592,360 180,049
2022-12-31 $550,134 189,050
2022-09-30 $502,927 197,227
2022-06-30 $312,563 140,795
2022-03-31 $430,616 102,042
2021-12-31 $952,328 198,402
2021-09-30 $1,284,174 213,673
2021-06-30 $1,729,480 231,214
2021-03-31 $427,683 51,715
2020-12-31 $376,496 44,346
2020-09-30 $472,111 25,396
2020-06-30 $154,630 13,576
2020-03-31 $324,421 74,069